342 related articles for article (PubMed ID: 8627511)
1. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
J Pharmacol Exp Ther; 1996 May; 277(2):1010-5. PubMed ID: 8627511
[TBL] [Abstract][Full Text] [Related]
2. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
4. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.
Messina ES; Tyndale RF; Sellers EM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1608-14. PubMed ID: 9316878
[TBL] [Abstract][Full Text] [Related]
5. (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes.
Nunoya K; Yokoi Y; Kimura K; Kodama T; Funayama M; Inoue K; Nagashima K; Funae Y; Shimada N; Green C; Kamataki T
J Pharmacol Exp Ther; 1996 May; 277(2):768-74. PubMed ID: 8627557
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
[TBL] [Abstract][Full Text] [Related]
7. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
Pearce R; Greenway D; Parkinson A
Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
[TBL] [Abstract][Full Text] [Related]
8. Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism.
Murphy SE; Johnson LM; Pullo DA
Chem Res Toxicol; 1999 Jul; 12(7):639-45. PubMed ID: 10409404
[TBL] [Abstract][Full Text] [Related]
9. Roles of human CYP2A6 and 2B6 and rat CYP2C11 and 2B1 in the 10-hydroxylation of (-)-verbenone by liver microsomes.
Miyazawa M; Sugie A; Shimada T
Drug Metab Dispos; 2003 Aug; 31(8):1049-53. PubMed ID: 12867494
[TBL] [Abstract][Full Text] [Related]
10. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst.
Hong JY; Wang YY; Bondoc FY; Lee M; Yang CS; Hu WY; Pan J
Toxicol Appl Pharmacol; 1999 Oct; 160(1):43-8. PubMed ID: 10502501
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
15. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
Li Y; Li NY; Sellers EM
Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
[TBL] [Abstract][Full Text] [Related]
17. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.
Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T
Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656
[TBL] [Abstract][Full Text] [Related]
18. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.
Yamazaki H; Inoue K; Hashimoto M; Shimada T
Arch Toxicol; 1999 Mar; 73(2):65-70. PubMed ID: 10350185
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
Higashi E; Nakajima M; Katoh M; Tokudome S; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):508-14. PubMed ID: 17237153
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol.
Guitton J; Buronfosse T; Desage M; Flinois JP; Perdrix JP; Brazier JL; Beaune P
Br J Anaesth; 1998 Jun; 80(6):788-95. PubMed ID: 9771309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
